REPCELIT Trademark

Trademark Overview

On Friday, October 20, 2017, a trademark application was filed for REPCELIT with the United States Patent and Trademark Office. The USPTO has given the REPCELIT trademark a serial number of 87654326. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 14, 2020. This trademark is owned by Bellicum Pharmaceuticals, Inc.. The REPCELIT trademark is filed in the Pharmaceutical Products category with the following description:

Cells for medical or clinical use
repcelit

General Information

Serial Number87654326
Word MarkREPCELIT
Filing DateFriday, October 20, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 14, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 13, 2018

Trademark Statements

Goods and ServicesCells for medical or clinical use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 31, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBellicum Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHouston, TX 77030
Party NameBellicum Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHouston, TX 77030

Trademark Events

Event DateEvent Description
Monday, December 14, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 14, 2020ABANDONMENT - NO USE STATEMENT FILED
Saturday, May 2, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 30, 2020EXTENSION 4 GRANTED
Thursday, April 30, 2020EXTENSION 4 FILED
Thursday, April 30, 2020TEAS EXTENSION RECEIVED
Saturday, November 9, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 7, 2019EXTENSION 3 GRANTED
Thursday, November 7, 2019EXTENSION 3 FILED
Thursday, November 7, 2019TEAS EXTENSION RECEIVED
Tuesday, May 7, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 3, 2019EXTENSION 2 GRANTED
Friday, May 3, 2019EXTENSION 2 FILED
Friday, May 3, 2019TEAS EXTENSION RECEIVED
Wednesday, September 26, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 24, 2018EXTENSION 1 GRANTED
Monday, September 24, 2018EXTENSION 1 FILED
Monday, September 24, 2018TEAS EXTENSION RECEIVED
Tuesday, May 8, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 13, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 13, 2018PUBLISHED FOR OPPOSITION
Wednesday, February 21, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, February 5, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 30, 2018ASSIGNED TO EXAMINER
Tuesday, October 31, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, October 24, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

repcelit clinical medical cells